Hello, I would like to know more about Xinhua Pharmaceutical. Can you tell me about it? Thank you.

In 1993, Xinhua Pharmaceutical Factory exclusively initiated the establishment of the company through fundraising. In June 1995, the wholly state-owned Shandong Xinhua Pharmaceutical Group Co., Ltd. was established on the basis of Xinhua Pharmaceutical Factory. The group replaced Xinhua Pharmaceutical Factory as the controlling shareholder of the company. After the company's H shares are issued, the group company will still serve as the company's state-owned shareholder, holding and exercising state-owned equity.

The company is one of the three major pharmaceutical companies in my country and the largest manufacturer of antipyretic analgesics and caffeine in my country. In 1995, the company's antipyretic and analgesic drug production was 6,480 tons, an increase of 16% compared with 1994; in 1996, it increased by 28.7%, which was 14 percentage points higher than the growth rate of the national total production of similar products, accounting for 20.8% of the national total production of similar products. An increase of 2.4 percentage points compared with 1995. Caffeine production in 1995 was 950 tons, an increase of 11.8% compared with 1994; in 1996, it increased by 23% compared with 1995, 21.5 percentage points higher than the growth rate of the total production of this product in the country, accounting for 19.9% ??of the total national production, compared with 1995 An increase of 3.3 percentage points.

The current annual demand for caffeine in the world reaches 12,000 tons, and is increasing by 2-3 every year. The United States is the largest consumer country, with consumption exceeding 8,000 tons. my country is a major producer and exporter of caffeine. In 1996, more than 60% of the caffeine imported into the United States came from China. The caffeine produced by our company has passed the inspection and re-inspection of the US FDA and is exported to the United States. It is an inspection-free product. The high quality of the product enjoys a high reputation in domestic and foreign markets.

After approval by the Ministry of Foreign Trade and Economic Cooperation of China in November 1998, it was converted into a foreign-invested joint-stock company.

Production of western medicine, chemical raw materials (excluding dangerous goods), pharmaceutical equipment, medicinal glass, medical testing instruments and meters, technology transfer, services, technical consultation, technical training, and sales of self-developed projects Products produced by the enterprise; production, filling and sales of industrial oxygen and industrial nitrogen; Chinese medicinal materials, Chinese patent medicines, Chinese medicine pieces, chemical preparations, antibiotics, biochemical drugs, biological products, diagnostic drugs, and medical device products (limited to Sales of Class I and II medical device products), health food, and sales of stereotyped packaged foods (the above 11 items are limited to branch operations)